New nasal spray treats Delta variant infection in mice, indicating broad spectrum results
Researchers have shown a new compound delivered in a nasal spray is highly effective in preventing and treating COVID-19 caused by the Delta variant in mice. The researchers, including scientists at UBC, Université de Sherbrooke, and Cornell University, believe this is the first treatment of its kind proven to be effective against all COVID-19 variants […]
UBC team receives funding to profile biological properties of SARS-CoV-2 VoCs and evaluate their susceptibility to therapeutics
A UBC team led by Dr. François Jean has been funded to produce rapid and detailed characterizations of emerging SARS-CoV-2 variants of concern by CoVaRR-Net, a Canadian research network focused on emerging variants. Throughout the pandemic, mutations in the virus’ genome have produced VoCs such as the Delta variant, that enable the virus to spread […]
Dr. François Jean and international team identify a new and promising treatment for COVID-19 and variants
A new anti-viral drug could improve COVID-19 outcomes and survival rates — and is highly effective against multiple variants — according to a new study led by researchers at the University of British Columbia and Université de Sherbrooke. The drug, called N-0385, blocks the SARS-CoV-2 virus from entering human cells through its favoured cell gateways. […]